Time to stop screening for prostate cancer: Comment on “declines in prostate cancer incidence after changes in screening recommendations”
A partir de données issues des registres américains des cancers, cette étude analyse l'évolution de l'incidence du cancer de la prostate aux Etats-Unis après la publication, en 2008, des recommandations d'un groupe d'experts en défaveur de l'usage d'un dépistage à l'aide du PSA pour les hommes âgés de plus de 75 ans
Over the last decade, the evidence that screening for prostate cancer causes more harm than good has grown so much that the US Preventive Services Task Force recommended in 2008 against screening for prostate cancer in men 75 years or older, and more recently, recommended against screening men of any age. The data in the Research Letter by Howard suggest that many physicians agree with the recommendation not to screen older men. Given that the harms of screening (eg, false-positive results, increased worry, treatment-related morbidities such as incontinence and erectile dysfunction) outweigh the benefits for younger men as well, we hope to see a similar decrease in early prostate cancer incidence in young men.
Archives of Internal Medicine , commentaire, 2011